Clinical trial
Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy: a Prospective Observational Study
NCT05916040 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy: a Prospective Observational Study
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 28, 2024
- Completion date
- June 30, 2030
- Enrollment
- 35 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer